Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

By LabMedica International staff writers
Posted on 20 Jun 2025

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. More...

Since most treatments only slow disease progression, early diagnosis is critical for effective care. Now, researchers have developed a novel and affordable screening system that detects PD from the volatile organic compounds (VOCs) found in a person’s earwax.

This innovative approach from researchers at Zhejiang University (Hangzhou, China;) was the result of a study to explore the diagnostic potential of sebum-rich earwax as a more stable and protected source of VOCs linked to Parkinson’s. The idea builds on earlier findings that sebum composition changes in PD due to neurodegeneration, inflammation, and oxidative stress, resulting in a distinctive odor profile. Unlike facial sebum, which is exposed to external environmental conditions such as humidity and air pollution, earwax remains relatively uncontaminated, making it a reliable testing medium. To investigate this, the researchers collected earwax samples by swabbing the ear canals of 209 individuals, including 108 people diagnosed with PD. Using gas chromatography and mass spectrometry, they identified four VOCs that were significantly different in people with Parkinson’s: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. These VOCs emerged as potential biomarkers for the disease.

Based on this dataset, the team developed an artificial intelligence olfactory (AIO) system trained to detect PD by analyzing the VOC patterns. When tested, the AIO-based model demonstrated 94% accuracy in distinguishing between PD and non-PD samples, according to the ACS’ Analytical Chemistry report. The high level of precision highlights the system’s potential for early detection, especially since the test is non-invasive and inexpensive. This new AIO screening tool could serve as a first-line diagnostic method to catch PD in its earliest stages, well before traditional symptoms appear. By enabling earlier medical intervention, it may improve long-term care outcomes for patients and streamline diagnosis in both clinical and community healthcare settings.

“This method is a small-scale single-center experiment in China,” said researcher Hao Dong from Zhejiang University. “The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value.”


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.